Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-345748
Filing Date
2026-08-12
Accepted
2026-08-12 07:30:50
Documents
79
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-20260630.htm   iXBRL 10-Q 3539041
2 EX-31.1 stro-ex31_1.htm EX-31.1 16828
3 EX-31.2 stro-ex31_2.htm EX-31.2 16965
4 EX-32.1 stro-ex32_1.htm EX-32.1 8791
5 EX-32.2 stro-ex32_2.htm EX-32.2 8830
  Complete submission text file 0001193125-26-345748.txt   12754326

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20260630.xsd EX-101.SCH 1408491
83 EXTRACTED XBRL INSTANCE DOCUMENT stro-20260630_htm.xml XML 2673543
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 261265330
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)